Assistant Medical Director, ARTS Adult Outpatient Program
Recognition & Awards
Program Award, CU Public Health & General Preventive Medicine Residency
Awarded by residents to faculty member for outstanding teaching and mentorship.
I am interested in drug safety, concomitant use of medication, medical education, and buprenorphine waiver training.
School of Medicine,
Sugar S, Coyle T. Keep Your Pin Up: Students Combating Opioid Use Disorder Stigma with Lapel Pins. Harvard Public Health Review (HPHR) Journal. October 2022;50. DOI: 10.54111/0001/
Hale E, Coyle DT. Under-documented or Under-recognized? Comorbid ADHD in Emergency Department Patients with Addictive Disorders. Journal of Attention Disorders. November 2022;0(0). https://doi.org/10.1177/10870547221135800
Bortz C, Armistead I, Bonaguidi A, Coyle DT. Critical Incidents in Colorado’s Opioid Treatment Programs: A Comparison of the COVID-19 Pandemic to Previous Years. 53rd Annual Conference of the American Society of Addiction Medicine. Hollywood, FL, 04/2022.
Stewart S, Krueger J, Armistead I, Munro T, Klie K, Coyle DT. Addiction & Preventive Medicine Trainee Pilot Policy Advocacy Experience, Colorado 2021. California Society of Addiction Medicine: State of the Art in Addiction Medicine Conference. San Diego, CA, 08/2022.
Locke T, Coyle DT. Alcohol and public health do not mix well. Colorado Sun, 11/06/2022
Locke T, Sugar S, Coyle DT. Letter to the Editor: Future Analyses of Gabapentin. Pharmacy Times, December 2022. https://www.pharmacytimes.com/view/letter-to-the-editor-future-analyses-of-gabapentin-use
Kuehl C, Bortz C, Fussner H, Olson C, Russell N, Sumner RA, Coyle DT. How Do Colorado Public Libraries Respond to Patron Queries about Opioid Use Disorder? A Secret Shopper Study. Substance Use and Misuse. November 2022;28:1-6.
Coyle DT. Trigeminal Zoster with Drug-Induced Labial Angioedema Leading to Necrosis. Medicine and Pharmacy Reports, September 2021. DOI: 10.15386/MPR-2103
Coyle T, Tantillo TJ. LETTER TO THE EDITOR. J Opioid Manag. 2021 Nov-Dec;17(6):443-444. PubMed PMID: 34904692
Coyle DT, Woodworth TS, Moeny D, Staffa J, Meyer T, Woods C, Welch EC, Haynes K, Toh S, Maro JC. Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers. J Manag Care Spec Pharm. 2020 May;26(5):668-672. PubMed PMID: 32347183
Hale E, Coyle DT. Substance Use Disorder in Patients with Attention-Deficit/Hyperactivity Disorder. Lift the Label Feature; Colorado Family Physician Newsletter.